213
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Development and in vivo evaluation of chitosan nanoparticles for the oral delivery of albumin

, , , , &
Pages 329-337 | Received 06 Mar 2018, Accepted 19 May 2018, Published online: 18 Jun 2018

References

  • Abdelkader A, El-Mokhtar MA, Abdelkader O, Hamad MA, Elsabahy M, El-Gazayerly ON. 2017. Ultrahigh antibacterial efficacy of meropenem-loaded chitosan nanoparticles in a septic animal model. Carbohydr Polym. 174:1041–1050.
  • Bhumkar DR, Pokharkar VB. 2006. Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: a technical note. AAPS PharmSciTech. 7:E138–E143.
  • Borges O, Borchard G, Verhoef JC, de Sousa A, Junginger HE. 2005. Preparation of coated nanoparticles for a new mucosal vaccine delivery system. Int J Pharm. 299:155–166.
  • Bronze-Uhle E, Costa B, Ximenes V, Lisboa-Filho P. 2017. Synthetic nanoparticles of bovine serum albumin with entrapped salicylic acid. Nanotechnol Sci Appl. 10:11.
  • Caraceni P, Domenicali M, Tovoli A, Napoli L, Ricci CS, Tufoni M, Bernardi M. 2013. Clinical indications for the albumin use: still a controversial issue. Eur J Intern Med. 24:721–728.
  • Caraceni P, Tufoni M, Bonavita ME. 2013. Clinical use of albumin. Blood Transfus. 11:s18–s25.
  • Drechsler M, Garbacz G, Thomann R, Schubert R. 2014. Development and evaluation of chitosan and chitosan/Kollicoat® Smartseal 30 D film-coated tablets for colon targeting. Eur J Pharm Biopharm. 88:807–815.
  • Elgindy N, Elkhodairy K, Molokhia A, ElZoghby A. 2011. Biopolymeric nanoparticles for oral protein delivery: design and in vitro evaluation. J Nanomed Nanotechnol. 2:110.
  • Elsabahy M, Wooley KL. 2015. Data mining as a guide for the construction of cross-linked nanoparticles with low immunotoxicity via control of polymer chemistry and supramolecular assembly. Acc Chem Res. 48:1620–1630.
  • Elsabahy M, Zhang M, Gan SM, Waldron KC, Leroux JC. 2008. Synthesis and enzymatic stability of PEGylated oligonucleotide duplexes and their self-assemblies with polyamidoamine dendrimers. Soft Matter. 4:294–302.
  • Elzeny H, Zhang F, Ali EN, Fathi HA, Zhang S, Li R, El-Mokhtar MA, Hamad MA, Wooley KL, Elsabahy M. 2017. Polyphosphoester nanoparticles as biodegradable platform for delivery of multiple drugs and siRNA. DDDT. 11:483–496.
  • Fathi HA, Allam A, Elsabahy M, Fetih G, El-Badry M. 2017. Nanostructured lipid carriers for improved oral delivery and prolonged antihyperlipidemic effect of simvastatin. Colloids Surf B Biointerfaces. 162:236–245.
  • Fonseca DP, Khalil NM, Mainardes RM. 2017. Bovine serum albumin-based nanoparticles containing resveratrol: characterization and antioxidant activity. J Drug Deliv Sci Technol. 39:147–155.
  • Garcia-Martinez R, Andreola F, Mehta G, Poulton K, Oria M, Jover M, Soeda J, Macnaughtan J, De Chiara F, Habtesion A, et al. 2015. Immunomodulatory and antioxidant function of albumin stabilises the endothelium and improves survival in a rodent model of chronic liver failure. J Hepatol. 62:799–806.
  • Griffin BT, Guo J, Presas E, Donovan MD, Alonso MJ, O'Driscoll CM. 2016. Pharmacokinetic, pharmacodynamic and biodistribution following oral administration of nanocarriers containing peptide and protein drugs. Adv Drug Deliv Rev. 106:367–380.
  • Helmy AM, Elsabahy M, Soliman GM, Mahmoud MA, Ibrahim EA. 2017. Development and in vivo evaluation of chitosan beads for the colonic delivery of azathioprine for treatment of inflammatory bowel disease. Eur J Pharm Sci. 109:269–279.
  • Kumar PV, Sivaraj A, Elumalai E, Kumar BS. 2009. Carbon tetrachloride-induced hepatotoxicity in rats-protective role of aqueous leaf extracts of Coccinia grandis. Int J Pharm Tech Res. 1:1612–1615.
  • Liedtke C, Luedde T, Sauerbruch T, Scholten D, Streetz K, Tacke F, Tolba R, Trautwein C, Trebicka J, Weiskirchen R. 2013. Experimental liver fibrosis research: update on animal models, legal issues and translational aspects. Fibrogen Tissue Repair. 6:19.
  • Luo YY, Xiong XY, Tian Y, Li ZL, Gong YC, Li YP. 2016. A review of biodegradable polymeric systems for oral insulin delivery. Drug Deliv. 23:1882–1891.
  • Mekkawy AI, El-Mokhtar MA, Nafady NA, Yousef N, Hamad MA, El-Shanawany SM, Ibrahim EH, Elsabahy M. 2017. In vitro and in vivo evaluation of biologically synthesized silver nanoparticles for topical applications: effect of surface coating and loading into hydrogels. IJN. 12:759–777.
  • Morsi NG, Ali SM, Elsonbaty SS, Afifi AA, Hamad MA, Gao H, Elsabahy M. 2018. Poly(glycerol methacrylate)-based degradable nanoparticles for delivery of small interfering RNA. Pharm Dev Technol. 23:387–399.
  • Ogawa M, Matsuda Y, Kobayashi A, Mitani M, Makino Y, Matsui H. 2014. Plasma antithrombin levels correlate with albumin and total protein in gestational hypertension and preeclampsia. Pregnancy Hypertens. 4:174–177.
  • Rodkey FL. 1965. Direct spectrophotometric determination of albumin in human serum. Clin Chem. 11:478–487.
  • Samarajeewa S, Ibricevic A, Gunsten SP, Shrestha R, Elsabahy M, Brody SL, Wooley KL. 2013. Degradable cationic shell cross-linked Knedel-like nanoparticles: synthesis, degradation, nucleic acid binding, and in vitro evaluation. Biomacromolecules. 14:1018–1027.
  • Silva SM, Braga CR, Fook MV, Raposo CM, Carvalho LH, Canedo EL. 2012. Application of infrared spectroscopy to analysis of chitosan/clay nanocomposites. In: Theophanides TM, editor. Infrared Spectroscopy ? Materials Science, Engineering and Technology. InTech; p. 43.
  • Song M, Li L, Zhang Y, Chen K, Wang H, Gong R. 2017. Carboxymethyl-β-cyclodextrin grafted chitosan nanoparticles as oral delivery carrier of protein drugs. React Funct Polym. 117:10–15.
  • Taverna M, Marie AL, Mira JP, Guidet B. 2013. Specific antioxidant properties of human serum albumin. Ann Intensive Care. 3:4.
  • Wang C, Fu X, Yang L. 2007. Water-soluble chitosan nanoparticles as a novel carrier system for protein delivery. Chinese Sci Bull. 52:883–889.
  • Wang S, Liu H, Zhang X, Qian F. 2015. Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies. Protein Cell. 6:480–503.
  • Wiedermann CJ. 2007. Anti-inflammatory activity of albumin. Crit Care Med. 35:981–982.
  • Wong CY, Martinez J, Dass CR. 2016. Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities. J Pharm Pharmacol. 68:1093–1108.
  • Xu Y, Du Y. 2003. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int J Pharm. 250:215–226.
  • Yang F, Xia S, Tan C, Zhang X. 2013. Preparation and evaluation of chitosan-calcium-gellan gum beads for controlled release of protein. Eur Food Res Technol. 237:467–479.
  • Yin L, Wang Y, Wang C, Feng M. 2017. Nano-reservoir bioadhesive tablets enhance protein drug permeability across the small intestine. AAPS PharmSciTech. 18:2329–2335.
  • Zaman R, Othman I, Chowdhury EH. 2016. Carrier mediated systemic delivery of protein and peptide therapeutics. Curr Pharm Des. 22:6167–6191.
  • Zhang F, Elsabahy M, Zhang S, Lin LY, Zou J, Wooley KL. 2013. Shell crosslinked knedel-like nanoparticles for delivery of cisplatin: effects of crosslinking. Nanoscale. 5:3220–3225.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.